Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia

Journal of Psychiatry and Neuroscience

Volumn 35, Issue 2, 2010, Pages 95-104

  Ebdrup, Bjørn H ^a,b   Glenthøj, Birte ^a   Rasmussen, Hans ^a   Aggernaes, Bodil ^a   Langkilde, Annika R ^b   Paulson, Olaf B ^b,c   Lublin, Henrik ^a   Skimminge, Arnold ^b   Baaré, William ^b,c  

^a Mental Health Services CPH   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MAGNETOM TRIO 3-T; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN SIZE; BRAIN VENTRICLE; BRAIN VENTRICLE DILATATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEUS ACCUMBENS; POSITIVE AND NEGATIVE SYNDROME SCALE; PUTAMEN; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 77649280648     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: 10.1503/jpn.090049     Document Type: Article

References (49)

1. Shenton ME, Dickey CC, Frumin M, et al. A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
2. Ellison-Wright I, Glahn DC, Laird AR, et al. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008;165:1015-23.
3. Vita A, De Peri L, Silenzi C, et al. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006;82:75-88.
4. Steen RG, Mull C, McClure R, et al. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 2006;188:510-8.
5. Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophr Bull 2007;33:921-31.
6. Boos HB, Aleman A, Cahn W, et al. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry 2007;64:297-304.
7. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 2005;10:160-84.
8. Chakos MH, Schobel SA, Gu H, et al. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br J Psychiatry 2005;186:26-31.
9. Salgado-Pineda P, Baeza I, Perez-Gomez M, et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003;19:365-75.
10. Laakso MP, Tiihonen J, Syvalahti E, et al. A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia. Schizophr Res 2001;50:3-7.
11. Matsumoto H, Simmons A, Williams S, et al. Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biol Psychiatry 2001;49:824-31.
12. Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008;65:1017-32.
13. Van Haren NE, Pol HE, Schnack HG, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry 2008;63:106-13.
14. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, et al. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1936-43.
15. Glenthoj A, Glenthoj BY, Mackeprang T, et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 2007;154:199-208.
16. Scherk H, Falkai P. Effects of antipsychotics on brain structure. Curr Opin Psychiatry 2006;19:145-50.
17. Rajarethinam R, Upadhyaya A, Tsou P, et al. Caudate volume in off-spring of patients with schizophrenia. Br J Psychiatry 2007;191:258-9.
18. Ballmaier M, Schlagenhauf F, Toga AW, et al. Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res 2008;106:140-7.
19. Gunduz H, Wu H, Ashtari M, et al. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry 2002;51:801-8.
20. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr Res 2007;91:87-96.
21. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, et al. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 1998;55:905-12.
22. Nagel BJ, Schweinsburg AD, Phan V, et al. Reduced hippocampal volume among adolescents with alcohol use disorders without psychiatric comorbidity. Psychiatry Res 2005;139:181-90.
23. Rais M, Cahn W, Van Haren N, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 2008;165:490-6.
24. Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 2008;65:694-701.
25. Keshavan MS, Rosenberg D, Sweeney JA, et al. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 1998;155:774-8.
26. Shihabuddin L, Buchsbaum MS, Hazlett EA, et al. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry 1998;55:235-43.
27. Lang DJ, Kopala LC, Vandorpe RA, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry 2001;158:625-31.
28. Shihabuddin L, Buchsbaum MS, Hazlett EA, et al. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 2001;58:877-84.
29. Corson PW, Nopoulos P, Andreasen NC, et al. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol Psychiatry 1999;46:712-20.
30. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113.
31. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990;47:589-93.
32. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
33. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
34. Jovicich J, Czanner S, Greve D, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006;30:436-43.
35. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-51.
36. Cuadra MB, Cammoun L, Butz T, et al. Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Trans Med Imaging 2005;24:1548-65.
37. Yassa MA, Stark CE. A quantitative evaluation of cross-participant registration techniques for MRI studies of the medial temporal lobe. Neuroimage 2009;44:319-27.
38. Baare WF, van Oel CJ, Hulshoff Pol HE, et al. Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry 2001;58:33-40.
39. Cahn W, Hulshoff Pol HE, Bongers M, et al. Brain morphology in antipsychotic-naive schizophrenia: a study of multiple brain structures. Br J Psychiatry Suppl 2002;43:s66-72.
40. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 1969;11:1-21.
41. Meisenzahl EM, Rujescu D, Kirner A, et al. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 2001;158:1316-9.
42. Ettinger U, Kumari V, Chitnis XA, et al. Volumetric neural correlates of antisaccade eye movements in first-episode psychosis. Am J Psychiatry 2004;161:1918-21.
43. Chua SE, Cheung C, Cheung V, et al. Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophr Res 2007;89:12-21.
44. Abi-Dargham A, Gil R, Krystal J, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998;155:761-7.
45. Buchsbaum MS, Hazlett EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998;24:343-64.
46. Gur RE, Maany V, Mozley PD, et al. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998;155:1711-7.
47. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005;62:361-70.
48. Velakoulis D, Wood SJ, Wong MT, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006;63:139-49.
49. Nesvag R, Saetre P, Lawyer G, et al. The relationship between symptom severity and regional cortical and grey matter volumes in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:482-90.